We examined whether pretreatment of CLL cells with the PKCδ inhibitor Rottlerin for 2 h interfered with the increased expression of Notch2-TM and Notch2-IC induced by IL-4 at 24 h. The gene discussed is NOTCH2; the disease is B-cell chronic lymphocytic leukemia.